核酸分離・精製市場：エンドユーザー別、方法別、核酸タイプ別、地域別、2024年～2031年

核酸分離・精製市場の評価、2024年～2031年

正確な分子診断と標的治療へのニーズが高まり続ける中、個別化医療への需要の増加が核酸分離・精製市場の主要な促進要因になると予測されます。Verified Market Researchのアナリストによると、核酸分離・精製市場は、2024年には約48億8,000万米ドルの評価額を下回り、予測期間中に87億8,000万米ドルの評価額に達すると推定されます。

核酸分離・精製市場の急拡大は、主にバイオテクノロジーとゲノミクスの進歩の拡大が原動力となっており、市場のCAGRを大幅に押し上げると予測されています。これにより、市場は2024年から2031年にかけて8.40%のCAGRで成長すると予測されます。

核酸分離・精製市場定義/概要

核酸分離・精製は分子生物学において重要なプロセスであり、生物学的サンプルからDNA、RNA、その他の核酸を抽出・精製するように設計されています。これらのプロセスは、遺伝子研究、診断、治療開発など、さまざまな用途に不可欠です。核酸の単離・精製に用いられる技術は多様で、遠心分離、ろ過、磁気ビーズを用いたアプローチなどがあります。これらの工程で得られる核酸の品質と完全性は、その後の分析や応用にとって極めて重要です。

バイオテクノロジーとゲノミクスにおける進歩の増加が、核酸分離・精製市場の著しい成長を促しています。個別化医療に対する需要の高まりとハイスループット・シーケンス技術の進歩が、この市場の拡大に寄与すると予想されます。研究と臨床応用が進化し続ける中、効率的で信頼性の高い核酸分離・精製法の必要性が高まり、市場全体の成長を支えるものと予測されます。

核酸分離・精製市場の成長を促進する主な動向は？

核酸分離・精製市場の拡大は、次世代シーケンサー（NGS）技術の採用増加によって大きく後押しされています。NGS技術は、遺伝子研究、個別化医療、腫瘍学など様々な用途に不可欠なハイスループットシーケンス機能を提供することで、ゲノム研究に革命をもたらしました。Verified Market Researchによると、次世代シーケンシング（NGS）市場規模は2024年に88億7,000万米ドルと評価され、2024年から2031年の予測期間にCAGR 20.39%で、2031年には391億5,000万米ドルに達すると予測されています。

高品質の核酸サンプルの需要は、精密で正確なシーケンス結果の必要性によって推進されており、核酸分離・精製製品の市場をさらに押し上げると予想されます。その結果、分離・精製技術の進歩がNGSの効率と効果を高め、市場成長の拡大につながると予想されています。

核酸分離・精製市場に影響を与える主な抑制要因は？

核酸分離・精製市場は、高度な分離・精製装置の高コストによる大きな制約に直面しています。洗練された技術や試薬に必要な初期投資は、多くの研究室、特に開発途上地域の研究室にとっては法外なものです。

例えば、自動リキッドハンドリングプラットフォームやハイスループット精製機などの高度なシステムは、10万米ドル以上かかることもあり、そのため利用しやすさや採用が制限されています。このような高コストが、特に予算上の制約が多い地域では、市場の成長を抑制すると予測されます。核酸分離・精製製品の世界市場は、資金調達が困難な地域では成長率が鈍化すると推定されます。このように、装置や試薬の高コストが市場拡大の大きな障壁となり、業界全体の成長軌道に影響を与えると予想されます。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 核酸分離・精製市場：エンドユーザー別

• 病院および診断センター
• 学術研究機関
• 製薬会社およびバイオテクノロジー会社
• 受託研究機関（CRO）
• その他の最終ユーザー

第5章 核酸分離・精製市場：方法別

• カラムベースの分離
• 磁気ビーズベースの分離
• その他の方法

第6章 核酸分離・精製市場：核酸タイプ別

• ゲノムDNA分離
• プラスミドDNA分離
• RNA分離
• マイクロRNA（miRNA）分離

第7章 地域分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• QIAGEN N.V.（Netherlands）
• Thermo Fisher Scientific Inc.（US）
• Roche Diagnostics（Switzerland）
• Promega Corporation（US）
• Agilent Technologies Inc.（US）
• Merck KGaA, Darmstadt, Germany
• Beckman Coulter Life Sciences（US）
• GE Healthcare（US）
• Bio-Rad Laboratories, Inc.（US）
• Luminex Corporation（US）

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Nucleic Acid Isolation And Purification Market Valuation - 2024-2031

Increasing demand for personalized medicine is expected to be a key driver in the nucleic acid isolation and purification market, as the need for precise molecular diagnostics and targeted therapies continues to grow. According to the analyst from Verified Market Research, the Nucleic Acid Isolation And Purification Market is estimated to reach a valuation of USD 8.78 Billion over the forecast subjugating around USD 4.88 Billion valued in 2024.

The rapid expansion of the nucleic acid isolation and purification market is primarily driven by the growing advancements in biotechnology and genomics, which are anticipated to significantly boost the CAGR of the market. It enables the market to grow at aCAGR of 8.40% from 2024 to 2031.

Nucleic Acid Isolation And Purification Market: Definition/ Overview

Nucleic acid isolation and purification are critical processes in molecular biology, designed to extract and purify DNA, RNA, or other nucleic acids from biological samples. These processes are essential for a range of applications, including genetic research, diagnostics, and therapeutic development. Techniques employed in nucleic acid isolation and purification are varied and include methods such as centrifugation, filtration, and magnetic bead-based approaches. The quality and integrity of nucleic acids obtained through these processes are crucial for subsequent analysis and applications.

Increasing advancements in biotechnology and genomics are driving significant growth in the nucleic acid isolation and purification market. The rising demand for personalized medicine and advancements in high-throughput sequencing technologies are expected to contribute to this market's expansion. As research and clinical applications continue to evolve, the necessity for efficient and reliable nucleic acid isolation and purification methods is projected to increase, supporting the overall market growth.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

What are the Key Trends Driving Growth in the Nucleic Acid Isolation and Purification Market?

The expansion of the nucleic acid isolation and purification market is being significantly driven by the increasing adoption of next-generation sequencing (NGS) technologies. NGS technologies have revolutionized genomic research by providing high-throughput sequencing capabilities, which are essential for a variety of applications, including genetic research, personalized medicine, and oncology. According the Verified Market Research, the next-generation sequencing (NGS) market size was valued to be USD 8.87 Billion in the year 2024 and it is expected to reach USD 39.15 Billion in 2031, at a CAGR of 20.39% over the forecast period of 2024 to 2031.

The demand for high-quality nucleic acid samples is being propelled by the need for precise and accurate sequencing results, which is expected to further boost the market for nucleic acid isolation and purification products. Consequently, advancements in isolation and purification technologies are being anticipated to enhance the efficiency and effectiveness of NGS, leading to increased market growth.

What are the Key Restraints Affecting the Nucleic Acid Isolation and Purification Market?

The nucleic acid isolation and purification market faces significant constraints due to the high cost of advanced isolation and purification equipment. The initial investment required for sophisticated technologies and reagents can be prohibitive for many laboratories, particularly those in developing regions.

For instance, advanced systems such as automated liquid handling platforms and high-throughput purifiers can cost upwards of $100,000, which limits their accessibility and adoption. This high cost is projected to restrain market growth, particularly in regions where budget constraints are prevalent. It is estimated that the global market for nucleic acid isolation and purification products will experience slower growth rates in regions with less funding availability. Thus, the high cost of equipment and reagents is expected to be a significant barrier to market expansion, impacting the overall growth trajectory of the industry.

Category-Wise Acumens

Which is the Dominating End-User Segment in the Nucleic Acid Isolation and Purification Market?

According to VMR analyst, pharmaceutical and biotechnology companies are expected to dominate as the leading end-user segment. This dominance is attributed to the extensive use of nucleic acid isolation and purification techniques in drug discovery, development, and personalized medicine. It is anticipated that these companies will continue to drive demand due to their need for high-quality nucleic acid samples for genetic research, biomarker discovery, and therapeutic development.

The pharmaceutical and biotechnology sector is projected to account for the largest share of the market, driven by the increasing number of drug development projects and rising investments in biotechnology research.

Which Nucleic Acid Type is Expected to Experience Rapid Growth in the Nucleic Acid Isolation and Purification Market?

In the nucleic acid isolation and purification market, RNA isolation is projected to experience rapid growth compared to other nucleic acid types. This growth is largely driven by the rising prevalence of RNA-based therapies and the increasing use of RNA in molecular diagnostics and research.

The growing interest in RNA sequencing and the development of RNA-targeted treatments are anticipated to fuel demand for RNA isolation products. The RNA isolation segment is expected to witness a significant increase in market share, driven by advancements in RNA extraction technologies and the expanding applications of RNA in personalized medicine.

Country/Region-wise Acumens

What are the Key Factors Driving the Growth of the Nucleic Acid Isolation and Purification Market in North America?

According to VMR Analyst, in North America, the nucleic acid isolation and purification market is expected to experience substantial growth, driven by several key factors. The region's advanced healthcare infrastructure, significant investments in research and development, and high concentration of leading pharmaceutical and biotechnology companies are anticipated to contribute to its dominance.

The U.S. government allocated over USD 3.8 Billion to the

Human Genome Project

between 1990 and 2003, with funding provided by the National Institutes of Health (NIH) and the Department of Energy (DOE). Additionally, the NIH's "All of Us" Research Program has been granted USD 1.5 Billion over ten years starting from 2016. This initiative aims to enhance precision medicine by gathering comprehensive health data from a diverse population to better understand the impact of individual differences on health and treatment.

Additionally, the strong presence of academic research institutes and diagnostic centers in North America is likely to further support market expansion. The increasing adoption of next-generation sequencing (NGS) technologies and rising demand for personalized medicine are projected to drive the need for efficient nucleic acid isolation and purification solutions.

How is the Nucleic Acid Isolation and Purification Market Expected to Evolve in Asia Pacific?

In Asia Pacific, the nucleic acid isolation and purification market is projected to grow rapidly due to increasing investments in healthcare infrastructure and expanding research activities. The region's growing emphasis on biotechnology and genomics research, coupled with rising government funding for scientific research, is anticipated to drive market growth.

The increasing prevalence of chronic diseases and the expansion of diagnostic services are also expected to contribute to the demand for nucleic acid isolation and purification products. Moreover, the rise of local pharmaceutical and biotechnology companies and contract research organizations (CROs) is likely to further accelerate market expansion.

In 2020, Asia accounted for approximately 49.3% of global cancer cases, with around 9.5 million new diagnoses reported. However, the region's share of cancer-related deaths was notably higher, representing about 58.3% of the global total, translating to approximately 5.8 million fatalities. These statistics highlight Asia's significant burden of cancer, reflecting both the high incidence and mortality rates within the region.

Competitive Landscape

The Nucleic Acid Isolation And Purification Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.

Some of the prominent players operating in the nucleic acid isolation and purification market include:

Agilent Technologies, Inc.

Beckman Coulter Life Sciences

Bio-Rad Laboratories, Inc.

GE Healthcare

Luminex Corporation

Merck KGaA

Promega Corporation

QIAGEN N.V.

Roche Diagnostics

Thermo Fisher Scientific, Inc.

Latest Developments

In December 2023, Thermo Fisher Scientific Inc. introduced two new products: the Thermo Scientific KingFisher Apex Dx, an automated nucleic acid purification instrument, and the Applied Biosystems MagMAX Dx Pathogen/Viral NA Isolation Kit. These innovations are designed to enhance the isolation and purification of bacterial and viral pathogens from biological samples.

In November 2023, LGC Biosearch Technologies announced the acquisition of PolyDesign, a company specializing in solid support embedded frits used for DNA and RNA oligonucleotide synthesis and purification. This technology complements LGC's Nucleic Acid Chemistry product range.

In August 2023, CD Bioparticles introduced a new series of DNA Extraction and Purification Kits. These kits are designed for efficient and rapid isolation of various DNA types, including plasmid, genomic, cell-free (cfDNA), mitochondrial, tissue DNA, and PCR products.

In July 2023, INOVIQ Limited and Promega Corporation revealed a global marketing collaboration to promote Promega's Nucleic Acid purification systems and EXO-NET exosome capture technology.

In February 2023, Agilent Technologies, Inc. selected Fluor Corporation's Advanced Technologies & Life Sciences division to expand its oligonucleotide therapeutics manufacturing facility in Colorado, enhancing capabilities for synthesizing, lyophilizing, and purifying custom nucleic acid therapeutics.

In January 2023, QIAGEN launched the EZ2 Connect MDx platform, an automated solution for diagnostic labs that streamlines the purification of DNA and RNA from up to 24 samples in under 30 minutes.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Nucleic Acid Isolation And Purification Market, By The End User

• Hospitals and Diagnostic Centers
• Academic Research Institutes
• Pharma and Biotech Companies
• Contract Research Organizations (CROs)
• Additional Final Users

5. Nucleic Acid Isolation And Purification Market, By Method

• Column-based Isolation
• Magnetic Bead-based Isolation
• Other Methods

6. Nucleic Acid Isolation And Purification Market, By Nucleic Acid Type

• Genomic DNA Isolation
• Plasmid DNA Isolation
• RNA Isolation
• MicroRNA (miRNA) Isolation

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• QIAGEN N.V. (Netherlands)
• Thermo Fisher Scientific Inc. (US)
• Roche Diagnostics (Switzerland)
• Promega Corporation (US)
• Agilent Technologies Inc. (US)
• Merck KGaA, Darmstadt, Germany
• Beckman Coulter Life Sciences (US)
• GE Healthcare (US)
• Bio-Rad Laboratories, Inc. (US)
• Luminex Corporation (US)

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References